Good morning. My name is Amrita Singh and I, along with my colleague, Scott MacKendrick, am here on behalf of Bereskin and Parr LLP to provide feedback about the proposed amendments to the Patent Act and Industrial Design Act as set out in part 4, clauses 104 through 142 of Bill C-43, and to answer any questions you might have about those amendments.
Bereskin and Parr is a leading Canadian intellectual property law firm. The firm's practice is comprehensive, encompassing all aspects of intellectual property law, including patents, industrial designs, and IP litigation. A number of the firm's practitioners are consistently ranked as leading practitioners in IP law in Canada and around the world.
We're pleased to have been invited to provide comments on the proposed amendments, many of which provide welcome updates to Canadian patent and industrial design law. Thank you for this opportunity.
I'll begin by addressing the amendments proposed to the Patent Act. The changes to the Patent Act are designed to implement the patent law treaty, the objective of which is to streamline and harmonize formal requirements set by various countries for the filing of patent applications and the maintenance in force of patents, as well as certain additional patent and patent applications requirements related to the communication with applicants or their patent agents, representation and recording assignments, and the like.
The treaty is intended to provide filing date requirements and procedures to avoid loss of filing dates, mechanisms to avoid the unintentional loss of rights arising from a failure to comply with time limits, an internationally standardized set of formal requirements consistent with the patent cooperation treaty requirements, standardized forms, and simplified procedures.
The majority of the amendments will require clarification by the yet to be made public, and presumably not yet drafted, patent rules. Until the rules are made public, it remains to be seen what the full impact of changes to Bill C-43 will mean for Canadian patent law.
I will highlight two things that are of particular interest to us. Intervening rights is the first thing I'm going to speak about.
Presently, there's no provision in the Patent Act for so-called third party intervening rights for someone who takes actions during the time that a patent application might be deemed abandoned, but is later reinstated, where the actions would otherwise be found to infringe the patent as issued. All that the act currently provides is that if a patent is issued, the patent owner may obtain reasonable compensation for the otherwise infringing actions during the deemed abandoned period.
Bill C-43 appears to change this, allowing for innocent infringement as long as the actions are taken in good faith and during the timeframe to be set out in the patent rules. There is no requirement for such a term in the patent law treaty, and what “good faith” means will, most likely, have to be determined by judges. This injects some uncertainty into the patent regime and such uncertainty is almost certain to result in litigation before the Federal Court.
Furthermore, this is a removal of rights already present in the Patent Act and will adversely affect patentees regardless of the reasons why applications were deemed abandoned or for which fees were unpaid at some time.
The second point I will address is reinstatement of applications. Currently, an application is deemed abandoned if a required action is not taken. Once abandoned, the applicant has 12 months to reinstate the application by requesting reinstatement, paying a late fee, and taking the required action.
Under the amendments, however, there are certain circumstances where the applicant must show to the commissioner of patents that the failure to take the required action was notwithstanding the applicant taking due care. The treaty only requires unintentional delay as the basis for reinstatement and this basis has been adopted by the U.S. patent office, among others. Due care is a more onerous standard than the Patent Act currently provides and is likely to result in litigation before the Federal Court as well.